Study of Novel Spectacle Lenses for Myopia Control in Young Children
This study is looking at how well a new type of spectacle lens can help slow down the progression of myopia (nearsightedness) in young children. We are testing two kinds of single vision, impact-resistant spectacle lenses. The study aims to enroll 150 children between 6 and 8 years old who have nearsightedness within a specific range. We will measure how much a child's nearsightedness changes over 12 months to see if the new lens is effective. This research builds on previous studies to confirm results for younger children.
- Study design
- This is a randomized, controlled study where participants are assigned to one of two groups by chance. Neither the participants nor the researchers will know which lens type is being used, and it will take place at multiple locations.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome will be measured at 12 months, and these results will be used to predict 3-year treatment effectiveness.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
At a glance
Conditions
Where it's being run
14 sites across 9 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Spherical equivalent refraction12 months
Change in spherical equivalent refraction from baseline